Seastar Medical Says Clinical Trial Results Demonstrate Its SCD Significantly Lowered Mortality Rates Among Critically Ill Covid-19 Patients

T-Reuters
2022/06/07

LMF Acquisition Opportunities Inc :Seastar Medical Announces Publication Of Clinical Trial Results Demonstrating Its Scd Significantly Lowered Mortality Rates Among Critically Ill Icu Covid-19 Patients By Safely And Effectively Stopping Inflammation Causing Cytokine Storms.Seastar Medical - Patients Experienced Reductions In Activated Neutrophils And Monocytes.Seastar Medical - Reductions In Activated Neutrophils, Monocytes, Led To Reduction In Proinflammatory Cytokines And Improved Clinical Outcomes.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10